Cargando…

Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection

Detalles Bibliográficos
Autores principales:	Zeng, Guangting, Zhou, Yuchi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507223/ https://www.ncbi.nlm.nih.gov/pubmed/37732138 http://dx.doi.org/10.1016/j.lana.2023.100590

Ejemplares similares

Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection–response to Guangting Zeng and Yuchi Zhou
por: Adegunsoye, Ayodeji, et al.
Publicado: (2023)

Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine
por: Zeng, Guangting
Publicado: (2022)

Cardiovascular Complications Are the Executioners of Inpatient With SARS-CoV-2 Community-Acquired Pneumonia
por: Zeng, Guangting
Publicado: (2023)

Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection: a prospective nationwide cohort study in the United States
por: Adegunsoye, Ayodeji, et al.
Publicado: (2023)

Arthritis after SARS-CoV-2 infection
por: Baimukhamedov, Chokan, et al.
Publicado: (2021)

Dynamic Contrast-enhanced MRI Demonstrates Pulmonary Microvascular Abnormalities Months After SARS-CoV-2 Infection
por: Zhou, Iris Y., et al.
Publicado: (2023)

Isolated bulbar palsy after SARS-CoV-2 infection
por: Todisco, Massimiliano, et al.
Publicado: (2021)

Breakthrough SARS-CoV-2 Infections in Prison after Vaccination
por: Brinkley-Rubinstein, Lauren, et al.
Publicado: (2021)

SARS-CoV-2 shedding and infectivity
por: Atkinson, Barry, et al.
Publicado: (2020)

SARS-CoV-2 Infection in Children
por: Lu, Xiaoxia, et al.
Publicado: (2020)

Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection
por: Lin, Qingqing, et al.
Publicado: (2020)

Rebound of SARS-CoV-2 Infection after Nirmatrelvir–Ritonavir Treatment
por: Charness, Michael E., et al.
Publicado: (2022)

Poor Respiratory Health Following Relapsing SARS-CoV-2 Infection in Children with Cystic Fibrosis: Correspondence
por: Mandal, Mohanchandra, et al.
Publicado: (2022)

Re: Vertical transmission and humoral immune response following maternal infection with SARS-CoV-2 by Massalha et al.
por: Zeng, Guangting
Publicado: (2022)

Sunitinib reduces the infection of SARS-CoV, MERS-CoV and SARS-CoV-2 partially by inhibiting AP2M1 phosphorylation
por: Wang, Pei-Gang, et al.
Publicado: (2020)

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Standl, Fabian, et al.
Publicado: (2021)

Infection of human sweat glands by SARS-CoV-2
por: Liu, Jia, et al.
Publicado: (2020)

Protective humoral immunity in SARS-CoV-2 infected pediatric patients
por: Zhang, Yaguang, et al.
Publicado: (2020)

SARS-CoV-2 cell tropism and multiorgan infection
por: Liu, Jia, et al.
Publicado: (2021)

SARS-CoV-2 infection in conjunctival tissue
por: Liu, Yu-Chi, et al.
Publicado: (2020)

Dysbiosis in SARS-CoV-2–Infected Patients
por: Marazzato, Massimiliano, et al.
Publicado: (2021)

Neuropathology associated with SARS-CoV-2 infection
por: Glatzel, Markus, et al.
Publicado: (2021)

Neuropathology associated with SARS-CoV-2 infection
por: Egervari, Kristof, et al.
Publicado: (2021)

Neuropathology associated with SARS-CoV-2 infection
por: Nasrallah, MacLean P, et al.
Publicado: (2021)

Poor Respiratory Health Following Relapsing SARS-CoV-2 Infection in Children with Cystic Fibrosis: Authors’ Reply
por: Dhochak, Nitin, et al.
Publicado: (2022)

A case of probable Parkinson's disease after SARS-CoV-2 infection
por: Cohen, Mikhal E, et al.
Publicado: (2020)

The role of the exposome in promoting resilience or susceptibility after SARS-CoV-2 infection
por: Naughton, Sean X., et al.
Publicado: (2020)

Can SARS-CoV-2-infected women breastfeed after viral clearance?
por: Lang, Guan-jing, et al.
Publicado: (2020)

SARS-CoV-2 Infection after Vaccination in Health Care Workers in California
por: Keehner, Jocelyn, et al.
Publicado: (2021)

Neutralization Profile after Recovery from SARS-CoV-2 Omicron Infection
por: Rössler, Annika, et al.
Publicado: (2022)

Risk and course of SARS-CoV-2 infection in patients treated for hypothyroidism and hyperthyroidism
por: Brix, Thomas H, et al.
Publicado: (2021)

Dynamics of the SARS-CoV-2 antibody response up to 10 months after infection
por: Wang, Hao, et al.
Publicado: (2021)

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1
por: van Doremalen, Neeltje, et al.
Publicado: (2020)

Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement
por: Zang, Jinkai, et al.
Publicado: (2020)

Natural History of Asymptomatic SARS-CoV-2 Infection
por: Sakurai, Aki, et al.
Publicado: (2020)

Neurologic Features in Severe SARS-CoV-2 Infection
por: Helms, Julie, et al.
Publicado: (2020)

Prediction of Neurodevelopmental Outcomes in SARS-CoV-2 Infections
por: Madaan, Priyanka, et al.
Publicado: (2021)

Ct values and infectivity of SARS-CoV-2 on surfaces
por: Kampf, Günter, et al.
Publicado: (2021)

Practical measures for SARS-CoV-2 infection prevention
por: Fujikawa, Tatsuya
Publicado: (2022)

Observations on healthcare workers & SARS-CoV-2 infection
por: Barde, Prajak, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b56qnhjrn2ucur5ba3bdo97pu8